Repertoire Immune Medicines

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

• 26 Feb 2026Silent ANTI-CD8 Antibodies And Fusion Proteinsapplication
• 12 Feb 2026T Cell Epitopes Associated With Type 1 Diabetesapplication
• 23 Oct 2025T Cell Receptor Multimers And Uses Thereofapplication
• 27 Mar 2025CD8-TARGETED IL-12 Fusion Proteinsapplication
• 13 Jun 2024Peptide-mhc-immunoglobulin Multimers And Methods Of Use Thereofapplication
• 14 Sept 2023Barcodable Exchangeable Peptide-mhc Multimer Librariesapplication
• 24 Aug 2023Mhc Multimer Expression Constructs And Uses Thereofapplication
• 16 Feb 2023Compositions Of Hydrogels And Methods Of Use Thereofapplication
• 24 Mar 2022Peptide Libraries And Methods Of Use Thereofapplication
• 10 Mar 2022Methods Of Producing High Diversity Peptide Libraries And Promoting Protein Foldingapplication
• —Lipid Particles For Delivering A Payloadapplication
• —T Cell Receptor Multimers And Uses Thereofapplication

• 07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
• 30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
• 30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
• 29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
• 26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
• 26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.